Are We Ready to Ride the Wave of Artificial Intelligence? 

Description

This session—held 2 years after the release of ChatGPT—covers updates and advancements in the applications of generative AI (GenAI) in liver diseases. The discussion builds on previous introductory sessions at The Liver Meeting 2023 and Digestive Disease Week 2024. Presenters explore advanced topics including: (1) AI alignment, ie, ensuring that an AI system’s objectives align with human values and goals, such as whether AI gives factually correct and safe answers in response to questions about liver diseases; (2) commercially available AI tools deployed within EHRs and adjacent to EHRs (eg, AI scribe technologies) that have a hepatology focus; and (3) human-computer interactions in GenAI relevant to applications in clinical hepatology.